Historical Press Releases

For current press releases please see Investor Tab.
All Releases
OPKO and Bio-Reference Laboratories Announce Early Termination of the Waiting Period for Planned Acquisition
July 2, 2015
Bio-Reference Laboratories, Inc. Reports Solid Revenues and Earnings for Q2FY15
June 8, 2015
OPKO and Bio-Reference Laboratories To Hold Joint Conference Call to Discuss Merger
June 8, 2015
OPKO Health to Acquire Bio-Reference Laboratories
June 4, 2015
BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter Fiscal Year 2015
June 1, 2015
BioReference Laboratories Partners With Organizations Accelerating Medical Innovation
April 14, 2015
Bio-Reference Laboratories, Inc. Reports Over 15% Increase in Revenue; Net Income Up Over 100%, Year Over Year
March 5, 2015
BioReference Laboratories, Inc. Announces Earnings Date for First Quarter Fiscal Year 2015
February 26, 2015
BioReference Laboratories, Inc. Launches OnkoSight(TM), an Advanced Tumor Sequencing Program
February 25, 2015
BioReference Laboratories, Inc. Hires Industry Veteran, Joseph F. Donahue, to Lead New Business Group
February 12, 2015
BioReference Laboratories, Inc. Announces Quarterly and Yearly Record Revenues, Net Income and Patient Volumes
December 18, 2014
BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2014
December 11, 2014
BioReference Laboratories, Inc. Reports Record Quarterly Revenues and Patient Volumes for Third Quarter FY2014
August 27, 2014
BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter Fiscal Year 2014
August 20, 2014
BioReference Laboratories, Inc. Reports Record Quarterly Revenues and Patient Volumes for Second Quarter FY2014
June 5, 2014
BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter Fiscal Year 2014
May 29, 2014
Bio-Reference Laboratories, Inc. Announces That Robert Daber, Ph.D. Will Join Company as Director of R&D and Cancer Genetics
April 16, 2014
Bio-Reference Laboratories, Inc. Reports Revenue Growth Despite Reimbursement Pressure and Impactful Weather
March 4, 2014
BioReference Laboratories, Inc. Announces Earnings Date for First Quarter Fiscal Year 2014
February 25, 2014
Bio-Reference Laboratories, Inc. Announces Record Quarterly Revenues and Record Annual Revenues and Earnings Despite Significant 4th Quarter Headwinds
December 19, 2013
BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2013
December 12, 2013
BioReference Laboratories, Inc. Provides Guidance for FY13 and Q4FY13 Anticipated Results
November 27, 2013
BioReference Laboratories, Inc. Sued by Myriad Genetics, Confident in Its Position
October 22, 2013
BioReference Laboratories, Inc. Reports Sustained Growth on Strong Quarterly Results
August 29, 2013
BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter for Fiscal Year 2013
August 22, 2013
BioReference Laboratories, Inc. Announces Strategic Acquisition of Edge BioSystems' Service Business
August 21, 2013
BioReference Laboratories, Inc. Announces Strategic Acquisition
August 13, 2013
Bio-Reference Laboratories and Coastal VIM Clinic Partner to Provide Free Clinical Tests to Patients
August 8, 2013
Bio-Reference to License GeneTests.org from University of Washington
July 22, 2013
GeneDx to Launch Comprehensive Breast Cancer Genetic Test
June 13, 2013
UPDATE -- BioReference Laboratories, Inc. Reports Record Quarterly Results Based on Sustained Growth
June 6, 2013
BioReference Laboratories, Inc. Reports Record Quarterly Results Based on Sustained Growth
June 6, 2013
Bio-Reference Laboratories, Inc to Speak at William Blair & Company's 33rd Annual Growth Stock Conference
June 5, 2013
Bio-Reference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2013
May 30, 2013
BioReference Laboratories, Inc to Speak at the UBS Global Healthcare Conference
May 15, 2013
Bio-Reference Laboratories, Inc. to Speak at the Bank of America Merrill Lynch Health Care Conference
May 8, 2013
Bio-Reference Laboratories, Inc. Responds to an Employee Wrongful Termination Suit Filed Against it as Baseless and Without Merit
April 12, 2013
Bio-Reference Laboratories, Inc. Announces Strong Growth Resulting in Record First Quarter Revenue and Earnings
February 28, 2013
Bio-Reference Laboratories, Inc. Will Offer Non-Invasive Prenatal Testing (NIPT) From Natera
February 27, 2013
Bio-Reference Laboratories, Inc. Announces Earnings Will be Reported on February 28, 2013, Will Reflect Change in Presentation of Revenues and Bad Debt to Comply With Accounting Standards Update Topic 954; No Effect on Net Income or EPS From Update Implementation
February 25, 2013
Bergen County-based Bio-Reference Donates $100,000 to Hurricane Sandy New Jersey Relief Fund
December 18, 2012
Bio-Reference Laboratories, Inc. Announces Record Revenues and Earnings for Fourth Quarter and for Full Fiscal Year Despite Effects of Hurricane Sandy
December 6, 2012
BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2012
December 5, 2012
Bio-Reference to Launch Laboratorio Buena Salud, The First Nationwide Full-Service Hispanic Laboratory
October 10, 2012
Bio-Reference Laboratories, Inc. Reports Best Quarterly Revenues and Earnings in Corporate History with 25% Increase in Earnings Per Share
August 30, 2012
BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter Fiscal Year 2012
August 23, 2012
GenPath Diagnostics of BioReference Laboratories, Inc. Awarded 2012 Clinical Diagnostics Company of the Year Award by Frost & Sullivan
June 26, 2012
Bio-Reference Laboratories, Inc. Reports Strong Quarterly Results
June 7, 2012
BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter Fiscal Year 2012
May 31, 2012
BRLI Announces InCellDx Investment and Launch of GenCerv Test Through its GenPath Women’s Health Laboratory
April 30, 2012
Bio-Reference Laboratories, Inc. Announces Record First Quarter Revenue, Earnings and Cash Flow from Operations
March 1, 2012
Bio-Reference Laboratories, Inc. Announces Earnings Date for First Quarter Fiscal Year 2012
February 23, 2012
BioReference Announces 2012 Annual Meeting Date
February 8, 2012
BioReference to Launch Groundbreaking Solid Tumor Genotyping Test through its GenPath Oncology Laboratory
January 26, 2012
BioReference Laboratories, Inc. Announces Contract with Corizon, Inc. to Provide Correctional Healthcare Laboratory Services
January 12, 2012
Bio-Reference Laboratories, Inc. Announces Record Revenues, Earnings and Cash Flow for Fourth Quarter and Full Fiscal Year
December 8, 2011
BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2011
December 7, 2011
BioReference Laboratories, Inc. to Speak at the Oppenheimer 22nd Annual Healthcare Conference
December 7, 2011
Bio-Reference Laboratories, Inc. and McKesson Specialty Health's Onmark GPO Execute Purchasing Agreement
November 22, 2011
Bio-Reference Laboratories' CEO Marc Grodman MD Speaks at Capitol Hill Policy Forum on the Contribution Genetic Tests Are Making to Cancer Care
November 18, 2011
Bio-Reference Laboratories Named 8th Fastest Growing Company in State of New Jersey
November 15, 2011
Bio-Reference Laboratories, Inc. Announces Stock Buy-Back Plan
November 11, 2011
BioReference Laboratories, Inc to Speak at the Lazard Capital Markets 8th Annual Healthcare Conference
November 9, 2011
GenPath Women's Health in Collaboration with GeneDX to Launch Breakthrough in Genetic Screening for Family Planning
October 27, 2011
GeneDxUnveils Groundbreaking Test to Identify Rare Inherited Diseases
October 12, 2011
BioReference Laboratories, Inc to Speak at the UBS Global Life Sciences Conference
September 13, 2011
Bio-Reference Laboratories, Inc. Reports 26% increase in Net Income, 22% increase in Net Revenue, 20% increase in Patient Count
August 25, 2011
BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter, Fiscal Year 2011
August 18, 2011
BioReference Laboratories, Inc to Speak at William Blair & Company's 31st Annual Growth Stock Conference
June 8, 2011
BioReference Laboratories, Inc. to Speak at the 2011 Jefferies Global Healthcare Conference
May 31, 2011
CORRECTING and REPLACING Bio-Reference Laboratories, Inc. Reports Record Quarterly Success
May 26, 2011
Bio-Reference Laboratories, Inc. Reports Record Quarterly Success
May 26, 2011
BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2011
May 19, 2011
BioReference Laboratories, Inc. to Speak at the Bank of America Merrill Lynch Health Care Conference
May 3, 2011
BioReference Laboratories, Inc. Reports 23% Revenue, 20% Patient Count Increase in Solid Quarterly Results
March 3, 2011
BioReference Laboratories, Inc. Announces Earnings Date for First Quarter for Fiscal Year 2011
February 24, 2011
Bio-Reference Laboratories, Inc. Announces Record Revenues and Earnings for Fourth Quarter and Fiscal Year
December 16, 2010
BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2010
December 9, 2010
Bio-Reference Laboratories, Inc. Announces Massachusetts General Hospital Agreement for Collaboration
November 30, 2010
BioReference Laboratories, Inc. to Speak at the Lazard Capital Markets 7th Annual Healthcare Conference
November 10, 2010
BioReference Laboratories, Inc. to Speak at the UBS Global Life Sciences Conference
September 13, 2010
Bio-Reference Laboratories, Inc. Announces 25% Revenue Growth, 17% Patient Growth, Record Income
August 26, 2010
BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter for Fiscal Year 2010
August 19, 2010
Bio-Reference Laboratories, Inc. Reports Record Quarterly Revenues
May 27, 2010
BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2010
May 20, 2010
BioReference Laboratories, Inc. to Speak at the Bank of America Merrill Lynch Health Care Conference
May 4, 2010
BioReference Laboratories, Inc. Announces 2 for 1 Stock Split
April 7, 2010
BioReference Laboratories, Inc. Reports Sustained Growth from All Business Units in the First Quarter
March 4, 2010
BioReference Laboratories, Inc. Announces Earnings Date for First Quarter for Fiscal Year 2010
February 25, 2010
BioReference Laboratories, Inc to Speak at the UBS 20th Annual Global Healthcare Services Conference
February 1, 2010
BioReference Laboratories, Inc to Speak at theJefferies 2010 Global Healthcare Services Conference
January 19, 2010
Bio-Reference Laboratories, Inc. Announces Record Revenues and Earnings for Fourth Quarter and Fiscal Year
December 17, 2009
BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2009
December 10, 2009
Bio-Reference Laboratories, Inc. Again Awarded New York State Department of Corrections Laboratory Services Contract
November 5, 2009
BioReference Laboratories, Inc to Speak at the Oppenheimer 20th Annual Health Care Conference
October 27, 2009
BioReference Laboratories, Inc to Speak at the UBS Global Life Sciences Conference
September 14, 2009
Bio-Reference Laboratories, Inc. Announces Continued Strong Growth Across All Laboratory Divisions
September 2, 2009
BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter for Fiscal Year 2009
August 26, 2009
BioReference Laboratories, Inc. to Speak at the Jefferies 3rd Annual Healthcare Conference
June 12, 2009
BioReference Laboratories, Inc to speak at the William Blair 29th Annual Growth Stock Conference
June 5, 2009
Bio-Reference Laboratories, Inc. Reports Record Quarterly Revenues
June 4, 2009
BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2009
May 28, 2009
BioReference Laboratories, Inc. to speak at the Bank of America and Merrill Lynch 2009 Health Care Conference
May 6, 2009
BioReference Laboratories, Inc. Announces NextGen Sequencing for Dilated Cardiomyopathy (DCM) Testing
April 7, 2009
BioReference Laboratories, Inc. Reports Continued Growth in the First Quarter Led by Esoteric Testing
March 5, 2009
BioReference Laboratories, Inc. Announces Earnings Date for First Quarter for Fiscal Year 2009
February 26, 2009
BioReference Laboratories, Inc to Speak at The UBS Global Healthcare Services Conference
February 3, 2009
Bio-Reference Laboratories, Inc. Announces Restitution Agreement with Former Employee
January 26, 2009
Bio-Reference Laboratories, Inc. Announces Record-Breaking Year-End and Fourth Quarter Results
December 18, 2008
BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2008
December 11, 2008
BioReference Laboratories, Inc to Speak at the 2008 Credit Suisse Phoenix Health Care Conference
November 6, 2008
BioReference Laboratories, Inc to Speak at the Oppenheimer 19th Annual Health Care Conference
October 28, 2008
BioReference Laboratories, Inc to Speak at the UBS Global Life Sciences Conference
September 19, 2008
Bio-Reference Laboratories, Inc. Announces Continued Strong Growth Led by Solid Gains in Its Esoteric Testing Divisions
September 4, 2008
BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter for Fiscal Year 2008
August 28, 2008
Bio-Reference Laboratories, Inc. Announces K-ras Testing Availability Through GenPath
August 6, 2008
Bio-Reference Laboratories, Inc. Announces Stock Buy-Back Plan
July 14, 2008
BioReference Laboratories, Inc to Speak at the Jefferies Healthcare Conference
June 17, 2008
BioReference Laboratories, Inc. to Speak at the William Blair Annual Growth Stock Conference
June 13, 2008
Bio-Reference Laboratories, Inc. Reports Continued Sustained Growth on Record Quarterly Revenues
June 5, 2008
BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2008
May 29, 2008
BioReference Laboratories, Inc. to Speak at the Bank of America Securities HealthCare Conference
May 7, 2008
BioReference Laboratories, Inc to Speak at the Eleventh Annual Lehman Brothers Global Healthcare Conference
March 13, 2008
BioReference Laboratories, Inc. Reports 24% Increase in Revenues, Sees Continued Growth in All Market Segments
March 6, 2008
BioReference Laboratories, Inc. Announces Earnings Date for First Quarter for Fiscal Year 2008
February 28, 2008
BioReference Laboratories, Inc. to Speak at the UBS Global Healthcare Services Conference
February 6, 2008
BioReference Laboratories, Inc. to Speak at the JPMorgan Healthcare Conference
January 3, 2008
Bio-Reference Laboratories, Inc. Announces Record-Breaking Year-End and Fourth Quarter Results
December 20, 2007
BioReference Laboratories and PVT Announce Agreement to Install PVT Equipment at BioReference
December 18, 2007
BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2007
December 13, 2007
BioReference Laboratories, Inc. to Speak at the William Blair Small-Cap Growth Stock Conference
October 2, 2007
BioReference Laboratories, Inc. to Speak at the UBS Global Life Sciences Conference
September 21, 2007
BioReference Laboratories, Inc to Speak at the Credit Suisse HOLT: Under Followed Opportunities Conference
September 7, 2007
BioReference Laboratories, Inc to Speak at the Bear Sterns 20th Annual Healthcare Conference
September 7, 2007
BioReference Laboratories, Inc. Announces 35% Increase in Net Revenues, 50% Increase in Operating Income, Year Over Year
September 6, 2007
BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter for Fiscal Year 2007
August 30, 2007
BioReference Laboratories, Inc. to Speak at the Jefferies Healthcare Conference
June 20, 2007
Bio-Reference Laboratories, Inc. Reports Solid Growth on Record Quarterly Revenues
June 7, 2007
BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2007
May 31, 2007
BioReference Laboratories, Inc. to Speak at the Bank of America Securities Healthcare Conference
May 24, 2007
BIOREFERENCE LABORATORIES, INC. REPORTS 25% INCREASE IN REVENUES, STRONG INCREASE IN OPERATING INCOME AND AFTER TAX NET INCOME ON A Q OVER Q BASIS FOR Q1FY07
March 8, 2007
BIOREFERENCE LABORATORIES, INC. ANNOUNCES EARNINGS DATE FOR FIRST QUARTER FOR FISCAL YEAR 2007
March 1, 2007
BIOREFERENCE LABORATORIES ANNOUNCES NEW HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY ANCILLARY SERVICES ARRANGEMENT
February 28, 2007
BIOREFERENCE LABORATORIES, INC TO SPEAK AT THE SUSQUEHANNA SIGNIFICANT INVESTMENT OPTIONS IN HEALTHCARE CONFERENCE
February 23, 2007
BIOREFERENCE LABORATORIES, INC TO SPEAK AT THE UBS GLOBAL HEALTHCARE SERVICES CONFERENCE
February 5, 2007
BIOREFERENCE LABORATORIES REPORTS HORIZON BLUE CROSS BLUE SHIELD ANCILLARY SERVICES AGREEMENT TERMINATION; LABORATORY INTENDS TO CONTEST TERMINATION
January 22, 2007
BIOREFERENCE LABORATORIES, INC TO SPEAK AT THE JPMORGAN HEALTHCARE CONFERENCE
January 3, 2007
BIOREFERENCE LABORATORIES, INC. ANNOUNCES RECORD-BREAKING YEAR-END AND FOURTH QUARTER RESULTS
December 19, 2006
BIOREFERENCE LABORATORIES ANNOUNCES AETNA NATIONAL ANCILLARY SERVICES AGREEMENT EFFECTIVE DECEMBER 15, 2006
December 14, 2006
BIOREFERENCE LABORATORIES TO RING THE NASDAQ STOCK MARKET CLOSING BELL IN NEW YORK
December 13, 2006
Bio-Reference Laboratories, Inc. Announces Earnings Date for the Fiscal Year 2006
December 12, 2006
BIOREFERENCE LABORATORIES ANNOUNCES AETNA NATIONAL ANCILLARY SERVICES AGREEMENT EFFECTIVE DECEMBER 15, 2006
December 1, 2006
Bio-Reference Laboratories Announces Extension of Provider Participation Agreement with United Healthcare to Include Oxford Health Plans Effective January 2007
October 3, 2006
Bio-Reference Laboratories, Inc to Speak at the Noble Financial Group OnTrack Equity Conference
September 22, 2006
Bio-Reference Laboratories, Inc. to Speak at the UBS Global Life Sciences Conference
September 21, 2006
Bio-Reference Laboratories, Inc. Announces Agreement to Acquire Gene-Based Testing Laboratory, Third Quarter Results and Reaffirms Guidance for Year; Company Signals Major Initiative into Gene-Based Testing by Acquiring GeneDx
August 29, 2006
Bio-Reference Laboratories, Inc. Reports Solid Growth on Record Quarterly Revenues; Company Reports 18% Increase in Net Revenues and 93% Increase in Fully Taxed Net Income in Q2 Comparisons of FY06 to FY05
June 8, 2006
Bio-Reference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2006
June 1, 2006
Bio-Reference Laboratories, Inc. to Speak at the Banc of America Securities HealthCare Conference
May 12, 2006
Bio-Reference Laboratories, Inc. Posts 25% Increase in Q1 After-Tax Net Income Based on 17% Increase in Year over Year Revenues; Company Reports a 21% Increase in Operating Income for the Quarter over the Prior Year Same Quarter
March 9, 2006
Bio-Reference Laboratories, Inc. Announces Earnings Date for First Quarter Fiscal Year 2006
March 2, 2006
BioReference Laboratories, Inc. Announces Record Annual Revenues and Record Revenues and Operating Income for Q4FY05; Operating income for Q4FY05 tops Q4FY04 by 16%
January 5, 2006
Bio-Reference Introduces New Lab Procedure to Identify and Detect Early Onset of Prostate Cancer; Bio-Reference Finds Some High-Risk Patients with Normal PSA Results May Be at Risk for Prostate Cancer
January 4, 2006
Bio-Reference Laboratories, Inc. Announces Earnings Date for the Fiscal Year 2005
December 29, 2005
Bio-Reference CEO, Marc Grodman, M.D., to Speak on Pay-for-Performance; Dr. Grodman Will Present in a Washington G-2 Audio Conference on Wednesday, December 7th
December 2, 2005
Bio-Reference Laboratories, Inc to Speak at the Noble Financial Group Small Cap Conference
November 3, 2005
Bio-Reference Laboratories, Inc. to Speak at the UBS Global Life Sciences Conference
September 20, 2005
Bio-Reference Laboratories, Inc. Announces Best Ever Revenues on Positive Year over Year Operating Income and EPS; Third Quarter Revenues Increase over 19% and Nine Month Revenues Increase Nearly 22% on a Year over Year Comparison
September 7, 2005
Bio-Reference Laboratories, Inc. Announces Earnings Date for the Third Quarter of Fiscal 2005
August 31, 2005
Bio-Reference Laboratories, Inc. Announces PSIMedica Contract with Keenan & Associates, Inc.
August 23, 2005
Bio-Reference Laboratories, Inc. Announces Contract with Correctional Medical Services
June 22, 2005
Bio-Reference Laboratories, Inc. Reports Solid Growth on Record Quarterly Revenues; Company Reports 19% Increase for Q2 and 23% Increase in Net Revenues for First 6 Months of FY05; Announces Stock Buy Back Plan
June 2, 2005
Bio-Reference Laboratories, Inc. Announces Earnings Date for the Second Quarter of Fiscal 2005
May 26, 2005
Bio-Reference Laboratories, Inc. to Speak at the Banc of America Securities HealthCare Conference
May 12, 2005
Bio-Reference Laboratories Announces CareEvolve Selection by Healthvision
April 28, 2005
Bio-Reference Laboratories, Inc. Records 27% Increase in Q1 Net Revenues, Expands Infrastructure to Meet National Demands
March 3, 2005
Bio-Reference Laboratories Announces Strategic Alliance with BD and Introduction of GenFlow
February 25, 2005
Bio-Reference Laboratories, Inc. Announces Earnings Date for the First Quarter of Fiscal 2005
February 24, 2005
Bio-Reference Laboratories, Inc to Speak at the UBS Global Healthcare Services Conference
February 11, 2005
Bio-Reference Laboratories, Inc. Announces Record Results Across the Board for Q4 and All of FY2004
January 6, 2005
Bio-Reference Laboratories, Inc. Announces Earnings Date for the Fiscal Year 2004
December 28, 2004
Bio-Reference Laboratories, Inc. Announces Agreement with The Segal Company to Provide PSIMedica Analytical Services
December 7, 2004
Bio-Reference Laboratories, Inc. Named to the 2004 Forbes List of the 200 Best Small Companies
October 20, 2004
Bio-Reference Laboratories, Inc to Speak at the UBS Global Life Sciences Conference
September 24, 2004
Bio-Reference Laboratories, Inc. Announces 24% Increase in Quarterly Revenues, Best Ever Revenues and Earnings
September 9, 2004
Bio-Reference Laboratories, Inc. Announces Earnings Date for the Third Quarter of Fiscal 2004
September 7, 2004
Bio-Reference Laboratories, Inc. Acquires Molecular and Cytogenetics Laboratory
July 12, 2004
Bio-Reference Laboratories, Inc. Announces Indiana Correctional Healthcare Contract
July 7, 2004
Bio-Reference Laboratories, Inc. Added to Russell 3000 Index
June 30, 2004
Bio-Reference Laboratories, Inc. Named to the Fortune Small Business Latest 100 Fastest Growing Small Companies
June 29, 2004
Bio-Reference Laboratories, Inc. Announces Kansas Correctional Healthcare Contract
June 17, 2004
Bio-Reference Laboratories, Inc. Records Best Ever Earnings on 30% Quarterly Revenue Increase
June 3, 2004
CORRECTING and REPLACING Bio-Reference Laboratories, Inc. Announces PSIMedica Contract with Lockton Companies, Inc. to Control Health Care Costs
June 2, 2004
Bio-Reference Laboratories, Inc. Announces PSIMedica Contract with Lockton Companies to Control Health Care Costs
June 2, 2004
Bio-Reference Laboratories, Inc. Named to BusinessWeek's Latest 100 Top Hot Growth Stocks List
June 1, 2004
Bio-Reference Laboratories, Inc. Announces Earnings Date for the Second Quarter of Fiscal 2004
May 27, 2004
Bio-Reference Laboratories, Inc. to Speak at the Banc of America Securities HealthCare Conference
May 12, 2004
Bio-Reference Laboratories, Inc. Announces New 5 Year Contract with NY State Department of Corrections
March 30, 2004
Bio-Reference Laboratories, Inc. Records Best Ever First Quarter Revenues and Net Income
March 4, 2004
Bio-Reference Laboratories, Inc. Announces Earnings Date for the First Quarter of Fiscal 2004
February 26, 2004
Bio-Reference Laboratories, Inc. Announces Board of Directors Changes
February 11, 2004
Bio-Reference Laboratories, Inc. Announces That IMPATH INC. Has Started Suit Against One Of Its Employees
January 27, 2004
Bio-Reference Laboratories Announces Collaboration Agreement with Sysmex America to Further Advance Hematology Diagnostics
January 22, 2004
Bio-Reference Laboratories, Inc. Announces Record Operating Results For Q4 And All Of FY2003, Including Significant Gains in Net Revenues, Earnings and Net Income
January 8, 2004
Bio-Reference Laboratories, Inc. Announces Earnings Date for Fiscal Year 2003
December 30, 2003
Bio-Reference Laboratories Names Scientific Advisory Board Members
October 23, 2003
Bio-Reference Laboratories Names James Weisberger, M.D. To Medical Staff
September 25, 2003
Bio-Reference Laboratories, Inc. Announces That BioView DUET, a Cancer Diagnostic System, Has Received FDA Approval
September 18, 2003
Bio-Reference Laboratories, Inc. Awarded Statewide Pennsylvania Prison Lab Contract
September 16, 2003
Bio-Reference Laboratories, Inc. Announces Substantial Gains on Record Operating Results, Including a 53% Increase in Taxed Net Income on a 16% Increase in Net Revenues
September 4, 2003
Bio-Reference Laboratories, Inc. Announces Earnings Date For The Third Quarter Of Fiscal 2003
August 28, 2003
Bio-Reference Laboratories Names John M. Bennett, MD, Noted Leukemia/Lymphoma Authority, to Head Scientific Advisory Board
August 21, 2003
Bio-Reference's CareEvolve Subsidiary Executes New Contracts, Wins Award
August 20, 2003
Bio-Reference Laboratories, Inc. Awarded Spot on Fortune SB 'America's Fastest-Growing Small Public Companies' List
July 1, 2003
Bio-Reference Laboratories, Inc. to Speak at the Morgan Keegan & Company, Inc. Healthcare Conference
June 18, 2003
Bio-Reference Laboratories, Inc. Reports Record Revenues, Record Net Income Despite Adverse Conditions
June 5, 2003
Bio-Reference Laboratories, Inc. Announces Earnings Date for the Second Quarter of Fiscal 2003
May 21, 2003
Bio-Reference Laboratories Executes Strategic Marketing Agreement with BIOVIEW, Inc. for the Enhanced Molecular Diagnosis Of Cancer
April 23, 2003
Bio-Reference Laboratories CEO, Marc Grodman M.D., to Speak at the Wachovia Securities Cancer Diagnostics Conference
April 3, 2003
Bio-Reference Laboratories, Inc. Announces Additional Details of Stock Buy-Back Plan
March 6, 2003
Bio-Reference Laboratories, Inc. Affirms Guidance; Announces Stock Buy-Back Plan in Earnings Announcement
March 6, 2003
Bio-Reference Laboratories, Inc. Announces Earnings Date for the First Quarter of Fiscal 2003
February 27, 2003
Bio-Reference Laboratories, Inc to Speak at the UBS Warburg Global Healthcare Services Conference
January 28, 2003
Bio-Reference Laboratories Awarded New York State Prison Contract for Fifth Consecutive Year; Contract Valued at Approximately $7M
January 21, 2003
Bio-Reference Laboratories, Inc. Confirms Street Estimates on Conference Call
January 9, 2003
Bio-Reference Laboratories, Inc. Reports 168% Increase in Pre-Tax Income and 20% Increase in Revenue for Fiscal 2002
January 9, 2003
Bio-Reference Laboratories, Inc. Announces Date for 2002 Year End Earnings and Conference Call
January 2, 2003
Bio-Reference's CareEvolve Subsidiary Executes Contract With S.E.D. Medical Laboratories
December 19, 2002
Bio-Reference Laboratories, Inc. Adjusts Guidance and Announces 2002 Year End Earnings Date; Company On Track with Upgraded Guidance For Fiscal 2002
December 12, 2002